Biosimilars And Their Potential Role In Healthcare Affordability
Development of Biosimilars Biosimilars are biologic medicines that are developed to be similar to an already approved biologic drug, known as the reference product. While …
Development of Biosimilars Biosimilars are biologic medicines that are developed to be similar to an already approved biologic drug, known as the reference product. While …
Introduction Over the last few decades significant progress has been made in developing new cancer treatments. One of the most promising areas is immunotherapy drugs …
The global Lupus Therapeutic Market is estimated to be valued at US$ 30 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
The Global Biosimilars Market is estimated to be valued at USD 21.8 billion in 2023 and is expected to exhibit a CAGR of 15.9% over …